I would take this opportunity to thank my research supervisor, family and friends for their support and guidance without which this research would not have been possible.
DECLARATION
I, [type your full first names and surname here], declare that the contents of this dissertation/thesis represent my own unaided work, and that the dissertation/thesis has not previously been submitted for academic examination towards any qualification. Furthermore, it represents my own opinions and not necessarily those of the University.
Signed __________________ Date _________________
TABLE OF CONTENTS
ACKNOWLEDGEMENT2
DECLARATION3
CHAPTER 1 INTRODUCTION6
Background of the Study6
Introduction to Stem Cells11
CHAPTER 2: LITERATURE REVIEW14
Various types of Stem Cells14
Embryonic Stem Cells15
What laboratory tests are used to identify embryonic stem cells?16
Adult Stem Cells18
Induced pluripotent stem cell20
Mesenchymal Stem Cells23
Characteristics23
Clinical Implication of MSC25
The anatomy of ocular surface25
Cornea26
Homeostasis of ocular surface27
Limbal Epithelial Stem Cells28
Function of LESC28
Mesenchymal cells from limbal stroma of human eye30
CHAPTER 3: METHODOLOGY32
Research Design32
Literature Search32
Keywords33
Definition of Qualitative Research33
Research Method34
Literature Selection Criteria35
Search Technique35
CHAPTER 4: DISCUSSION AND RESULTS36
Stem cell research in orthopaedic and trauma surgery36
Stem cells37
Mesenchymal stem cells38
MSCs from bone marrow39
MSCs from other tissue40
Osteoblast differentiation from MSCs in bone marrow40
Clinical trials43
Clinical stem cell applications in the treatment of fractures44
Clinical stem cell research in osteonecrosis45
Cartilage injury46
Autologous Chondrocyte Implantation (ACI)49
Acquiring human embryos for stem-cell research50
The status of the embryo52
Surplus embryos from IVF54
Fresh embryos56
Embryos created for research57
Implications for women59
Totipotency, pluripotency and multipotency61
CHAPTER 5: CONCLUSION67
REFERENCES72
CHAPTER 1 INTRODUCTION
Background of the Study
An extensive body of information has been accumulated over the years concerning the differentiation potential of mammalian embryonic stem cells. These cells became a focus of intense public interest when, in 1998, James Thomson and colleagues announced their successful derivation from human embryos. Embryonic stem cells, derived from the inner cell mass at the blastocyst stage of embryo development, are not totipotent, i.e., they cannot give rise to a living organism. However, they are pluripotent, that is, under restrictive conditions, they can be propagated indefinitely in an undifferentiated state, and they can also be induced to differentiate into a wide range of cells and tissues. The lines of such pluripotent cells that are currently available to researchers were derived from embryos unused after infertility treatments that would otherwise be destroyed.
Another potential source of human pluripotent stem cells are embryos generated via somatic cell nuclear transfer into denucleated oocytes. Once successfully grown to the blastocyst stage, such cloned embryos would be destroyed in order to derive embryonic stem cells that hold the potential for the development of cell replacement therapies. Any cloning through human somatic cell nuclear transfer, if successful, necessarily involves the creation of a living human embryo and for this reason the technique raises profound ethical and moral questions and is highly controversial. There is at present an overwhelming international consensus directed against human reproductive cloning aimed at creating groups of genetically identical individuals by uterine transfer of embryos generated by somatic cell nuclear transfer.
There is also a vigorous debate over the use of pluripotent stem cell lines from human embryos for research aimed at cell replacement therapy as possible avenues for conquering disease. Animal experiments provide very encouraging ...